ECRM 2025: Key Trends & Opportunities

Archbow Consulting’s Kevin Cast and  Paul J Furgal recently attended the ECRM BrandRx & Vaccine Session in Ponte Vedra Beach, FL. The event brought together industry leaders to discuss critical aspects of the pharmaceutical landscape, including new product launches, distribution strategies, and patient support programs. We gained valuable insights into optimizing supply chain solutions and refining market access strategies.

Upon conclusion of our meetings, we identified the following key takeaways:

• Gross-to-net erosion was a major topic of discussion at ECRM, with many manufacturers seeking alternative distribution and dispensing models to address this challenge
• Artificial Intelligence and technology are revolutionizing Patient Support Services. The traditional, in-house support HUB model is facing disruption and could become obsolete in the next several years.
• Payer reimbursement of prescription products are decreasing more rapidly than ever, creating a challenging environment for pharmaceutical manufacturers
• GLP-1s have become a dominant force in the pharmaceutical market, with profound implications for the industry. Dramatic weight loss success is driving changes in food and beverage choices and fueling a surge in clothing purchases.
• Service vendors like Noble Health and Health Beacon are becoming vital for enhancing patient engagement. Their innovative technologies, including auto-injector training devices and smart sharps containers, are transforming patient support.
• Fair Market Value (FMV) for enhanced pharmacy services is experiencing a dynamic shift. While the appetite for an FMV is increasing for critical services like adherence calls, clinical programs, and advanced prior authorizations, it’s declining for others, such as data access and startup fees.